Abstract
The hypothalamic-pituitary-adrenal (HPA) axis seems to play an important role in obesity and Type 2 diabetes (DM). The aim of the present study was to determine the adrenal volume in obese patients with DM in comparison to obese non-diabetic patients. Eleven diabetic obese and 19 non-diabetic obese women were sequentially invited to take part in the study. Computed tomography (CT) scan of the abdomen was performed to determine adrenal volume, visceral (VF) and sc fat (SCF). Daily urinary free cortisol (UFC) was used as a measure of integrated cortisol production. In the diabetic patients, hemoglobin A1c was measured as an index of metabolic control. Compared to non-diabetic controls, patients with diabetes had a significantly higher total adrenal volume (4.29±1.50 vs 2.95±1.64; p=0.03). A highly significant correlation was detected between VF and VF/SCF ratio and total adrenal volume in the whole group (r=0.36, p=0.04 and r=0.48, p=0.008, respectively). This study, therefore, suggests an association between abdominal obesity, enlarged adrenals and Type 2 diabetes. These findings support the hypothesis that an increased activity of the HPA axis in obese subjects may be involved in the pathogenesis of Type 2 diabetes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bjorntorp P, Rosmond R. Obesity and Cortisol. Nutrition 2000, 16: 924–36.
Grassi G, Seravalle G, Dell’Oro R, et al. Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity. Hypertension 2001, 38: 1316–20.
Roy MS, Roy A, Brown S. Increased Urinary-free cortisol outputs in diabetic patients. J Diabet Complications 1998, 12: 24–7.
Fruehwald-Schultes B, Kern W, Bong W, et al. Supraphysiological Hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal axis secretory activity in humans. J Clin Endocrinol Metab 1999, 84: 3041–6.
Appel MC, Schibly BA, Kamara JA, Sorenson RL. Adrenal gland involvement in mice with hereditary obesity and diabetes mellitus. Morphological studies. Diabetologia 1979, 16: 391–8.
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20: 1183–97.
Pasquali, R, Vicennati V. The abdominal obesity phenotype and insulin resistance are associated with abnormalities of the hypothalamic-pituitary-adrenal axis in humans. Horm Metab Res 2000, 32: 521–5.
Bjorntorp P, Rosmond R. Neuroendocrine abnormalities in visceral obesity. Int J Obes 2000, 24 (Suppl 2): 580–5.
Shively C, Clarkson T. Regional obesity and coronary atherosclerosis in females: a non-human primate model. Acta Med Scand 1989, 723 (Suppl): 71–8.
Rask E, Olsson T, Doderberg S, et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001, 86: 1418–21.
Walker B. Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence? Growth Horm IGF Res 2001, 11 (Suppl A): S91–5.
Lottenberg SA, Giannella-Neto D, Derendorf H, et al. Effect of fat distribution on the pharmacokinetics of cortisol in obesity. Int J Clin Pharmacol Ther 1998, 36: 501–5.
Vicennati V, Pasquali R. Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration. J Clin Endocrinol Metab 2000, 85: 4093–8.
Chan O, Inouye K, Riddell MC, Vranic M, Matthews SG. Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis. Minerva Endocrinol 2003, 28: 87–102.
Pasquali R, Ambrosi B, Armanini D, et al. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. J Clin Endocrinol Metab 2002, 87: 166–75.
Attia N, Tamborlane WV, Heptulla R, et al. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab 1998, 83: 1467–71.
Maccario M, Grottoli S, Procopio M et al. The GH/IGF-I axis in Obesity: Influence of neuro-endocrine and metabolic factors. Int J Obes 2000, 24 (Suppl 2): S96–9.
Reincke M, Fassnacht M, Vath S, Mora P, Allolio B. Adrenal incidentalomas: a manifestation of the metabolic syndrome. Endocr Res 1996, 22: 757–61.
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes. Diabetes Care 2001, 24: 1069–78.
Linkowski P, Mendlewicz J, Leclercq R, et al. The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab 1985, 61: 429–38.
Amsterdam JD, Marinelli DL, Arger P, Winokur A. Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: a pilot study. Psychiatry Res 1987, 21: 189–97.
Rubin RT, Phillips JJ, Sadow TF, McCracken JT. Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Arch Gen Psychiatry 1995, 52: 213–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Godoy-Matos, A.F., Vieira, A.R., Moreira, R.O. et al. The potential role of increased adrenal volume in the pathophysiology of obesity-related Type 2 diabetes. J Endocrinol Invest 29, 159–163 (2006). https://doi.org/10.1007/BF03344090
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03344090